Skip to main content

COVID-19 Information for Cancer Researchers

COVID-19 Updates from NCI

Stay up to date with how NCI is adapting to the extraordinary circumstances imposed on the cancer community by COVID-19.

During the COVID-19 pandemic, NCI is continuing to advance cancer research while using its unique resources to help in the response to the pandemic.

Much of NCI's COVID-19 research will be done at the NCI-sponsored Frederick National Laboratory for Cancer Research in collaboration with other agencies, academic institutions, and research organizations. NCI is also funding extramural research on COVID-19.

On this page, you will find links to resources and guidance for extramural and intramural researchers and information about NCI's research related to COVID-19.

NCI COVID-19 Research

  • NCI COVID-19 Research Initiatives

    There is a lot to learn about how COVID-19 affects people, including those with cancer, and how to treat the disease. NCI is mobilizing its scientific experts and cutting-edge resources to conduct research on COVID-19.

  • NCI-Supported Clinical Trials for Coronavirus

    List of ongoing clinical trials for coronavirus disease 2019 (COVID-19) supported by the National Cancer Institute. Some trials may be specifically for people with cancer who also have coronavirus disease.

Resources for COVID-19 Research

  • Human SARS-CoV-2 Serology Standard

    This pool of plasma from four donors with antibodies to the SARS-CoV-2 spike and nucleocapsid proteins is available by request to labs conducting COVID-19 antibody testing to enhance cross-study comparisons. The standard was developed by the Frederick National Laboratory for Cancer Research’s Serology Lab and will be used by the NCI Serological Sciences Network (SeroNet) and other scientists conducting COVID-19-related serology research.

  • Guidance for Serology Research

    SeroNet investigators have created guidance documents for researchers conducting studies on the immune response to vaccines to encourage harmonization across studies and to allow for cross-study comparisons. The available documents include study design templates, standard operating procedures, and common data elements.

Guidance for Extramural Researchers

Guidance for Clinical Trial Investigators

Guidance for Intramural Researchers